(Q44105671)

English

Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia

scientific article published on January 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1516599

4 October 2022

hypercholesterolemia

0 references

author name string

B. G. Jacob

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1516599

4 October 2022

W. Möhrle

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1516599

4 October 2022

W. O. Richter

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1516599

4 October 2022

P. Schwandt

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1516599

4 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1516599

4 October 2022

publication date

1 January 1992

1 reference

Europe PubMed Central

29 November 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

29 November 2017

42

1 reference

Europe PubMed Central

29 November 2017

353-358

1 reference

Europe PubMed Central

29 November 2017

4

1 reference

Europe PubMed Central

29 November 2017

The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New horizons in combination drug therapy for hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects. A double blind test

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human apolipoprotein molecular biology and genetic variation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of lovastatin on concentrations and composition of lipoprotein subfractions

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term administration of lovastatin in the treatment of hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term clinical tolerance of lovastatin and simvastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of plasma cholesterol by lipoprotein receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CS-514 on plasma lipids and lipoprotein composition in hypercholesterolemic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and long-term adverse effect pattern of lovastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1516599

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00280117

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1516599

4 October 2022

1 reference

Europe PubMed Central

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44105671&oldid=1742687285"